June 04, 2026
A Delaware bankruptcy judge on Thursday agreed to conditionally approve the disclosure statement for biotechnology company Alachua Government Services' Chapter 11 liquidation plan after the debtor announced it had settled a long-running outstanding dispute.
June 02, 2026
The U.S. government has asked a Delaware bankruptcy judge to reject Alachua Government Services' disclosure statement for its liquidation plan, saying the biotechnology company is proposing to shortchange the Department of Defense's claims against the debtor.
February 09, 2026
Biotechnology company Alachua Government Services received approval on Monday from a Delaware bankruptcy judge for a $16 million sale to healthcare investment firm OrbiMed Advisors LLC of the royalty rights to a line of monkey cells being used to develop a smallpox vaccine.
January 21, 2026
Biotech company Alachua Government Services has won approval to enter into a $10.3 million stalking horse bid from Emergent Biosolutions Inc. for a line of monkey cells being used to develop a smallpox vaccine.
December 05, 2025
A Delaware bankruptcy judge Friday gave a Florida biotechnology company permission to hold an auction in January for the royalty rights to a line of monkey cells being used to develop a smallpox vaccine.